What prices were reported for Christopher A. Caldwell’s CNXC share disposals?

Christopher A. Caldwell reported disposing of Concentrix common stock at $43.22 per share on January 24, 2026, for 10,105 shares, and at $42.69 per share on January 26, 2026, for 1,751 shares, according to the Form 4 insider transaction disclosure.

Concentrix CEO Caldwell reports share disposals

Concentrix Corp President and CEO Christopher A. Caldwell reported two share disposals of company common stock.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Concentrix Corp President and CEO Christopher A. Caldwell reported two share disposals of company common stock. On January 24, 2026, he disposed of 10,105 shares at $43.22 each. On January 26, 2026, he disposed of 1,751 shares at $42.69 each.

After these transactions, Caldwell directly beneficially owned 363,772 shares following the first transaction and 362,021 shares following the second transaction, reflecting his remaining direct common stock holdings in Concentrix Corp.

Insider Trade Summary

Exercise Price or Tax Liability: 11,856 shares

Exercise Price or Tax Liability 2 txns

Insider Caldwell Christopher A

Role President and CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,751	$42.69	$75K
Exercise Price or Tax Liability	Common Stock	10,105	$43.22	$437K

Holdings After Transaction: Common Stock — 362,021 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Christopher A. Caldwell report for CNXC?

Christopher A. Caldwell reported two dispositions of Concentrix Corp common stock. On January 24, 2026, he disposed of 10,105 shares at $43.22, and on January 26, 2026, he disposed of 1,751 shares at $42.69, all reported as direct holdings.

How many Concentrix (CNXC) shares does Christopher A. Caldwell hold after these transactions?

Following the reported transactions, Christopher A. Caldwell directly beneficially owned 363,772 Concentrix shares after the January 24, 2026 transaction and 362,021 shares after the January 26, 2026 transaction, showing his remaining direct stake in Concentrix Corp common stock.

On what dates did the CNXC insider transactions by Christopher A. Caldwell occur?

The reported Concentrix insider transactions occurred on January 24, 2026 and January 26, 2026. Both transactions involved common stock and were coded “F,” with share disposals and corresponding prices disclosed in the Form 4 filing for Christopher A. Caldwell.

What is Christopher A. Caldwell’s role at Concentrix Corp (CNXC)?

Christopher A. Caldwell is identified as both a Director and the President and CEO of Concentrix Corp. His positions are disclosed in the Form 4, indicating he is a senior executive officer as well as a member of the company’s board of directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 01/27/2026 - 04:46 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caldwell Christopher A

(Last)

(First)

(Middle)

39899 BALENTINE DRIVE

SUITE 235

(Street)

NEWARK

94560

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/24/2026		F		10,105	D	$43.22	363,772	D
Common Stock	01/26/2026		F		1,751	D	$42.69	362,021	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:

	/s/ Andrew A. Farwig, Attorney-in-Fact	01/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR